Literature DB >> 28131872

Atypical pituitary adenoma with orbital invasion: Case report and review of the literature.

Mina M Naguib1, Pia R Mendoza2, Supharat Jariyakosol3, Hans E Grossniklaus4.   

Abstract

Pituitary adenoma invasion into the orbit is a rare phenomenon with only 22 cases, including the present case, in the literature. Our case is a 31-year-old man who presented with biopsy-proven atypical pituitary adenoma invading the right orbit after a prior resection. We compare his clinical course with previous cases and discuss clinical features, radiological features, management considerations, histologic features, and prognosis. Cases are organized by specific pituitary tumor type to aid in determining appropriate management. Early surgical intervention is the key, especially in the setting of pathologic features indicating aggressive tumor behavior or worsening visual function but is generally not indicated in prolactin-secreting adenomas that may respond to medical therapy. The role of radiation therapy is not fully established; however, it should be strongly considered in conjunction with or after surgery, especially in cases where complete resection is not achieved or histological and molecular analyses indicate a high likelihood of recurrence. More uniform and comprehensive data about management and outcomes are needed to determine the optimal treatment approach for this rare entity.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atypical pituitary adenoma; ocular oncology; orbital invasion; pituitary tumors

Mesh:

Substances:

Year:  2017        PMID: 28131872      PMCID: PMC5526750          DOI: 10.1016/j.survophthal.2017.01.005

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  23 in total

1.  Orbital tumours.

Authors:  H JACKSON
Journal:  J Neurosurg       Date:  1962-07       Impact factor: 5.115

Review 2.  Pathogenesis of pituitary tumors.

Authors:  Shlomo Melmed
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

Review 3.  Diagnosis and treatment of pituitary adenomas.

Authors:  P Chanson; S Salenave
Journal:  Minerva Endocrinol       Date:  2004-12       Impact factor: 2.184

4.  Orbital invasion by pituitary adenoma.

Authors:  P H Spiegel; Z A Karcioglu
Journal:  Am J Ophthalmol       Date:  1994-02-15       Impact factor: 5.258

5.  Massive prolactinoma with galactorrhoea in a prepubertal boy.

Authors:  R J Ross; J M McEniery; A Grossman; I Doniach; G M Besser; M O Savage
Journal:  Postgrad Med J       Date:  1989-06       Impact factor: 2.401

6.  Unsuspected recurrent pituitary adenoma presenting as an orbital mass.

Authors:  F P Bernardini; R C Kersten; M Moin; D R Kulwin
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2001-03       Impact factor: 1.746

Review 7.  The prevalence of pituitary adenomas: a systematic review.

Authors:  Shereen Ezzat; Sylvia L Asa; William T Couldwell; Charles E Barr; William E Dodge; Mary Lee Vance; Ian E McCutcheon
Journal:  Cancer       Date:  2004-08-01       Impact factor: 6.860

Review 8.  Best Practice No 172: pituitary gland pathology.

Authors:  J W Ironside
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

9.  Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).

Authors:  Alberto Fernandez; Niki Karavitaki; John A H Wass
Journal:  Clin Endocrinol (Oxf)       Date:  2009-07-24       Impact factor: 3.478

10.  Orbital invasion by ACTH-secreting pituitary adenomas.

Authors:  Jasmeet S Dhaliwal; Leonard K Seibold; B K Kleinschmidt-Demasters; Kevin O Lillehei; Eric M Hink; J Adair Prall; Vikram D Durairaj
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2014 Mar-Apr       Impact factor: 1.746

View more
  2 in total

1.  Long non-coding RNA TUG1/microRNA-187-3p/TESC axis modulates progression of pituitary adenoma via regulating the NF-κB signaling pathway.

Authors:  Rui Zhang; Fan Yang; Haitao Fan; Haocong Wang; Qinghao Wang; Jianxin Yang; Tao Song
Journal:  Cell Death Dis       Date:  2021-05-21       Impact factor: 8.469

2.  Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas.

Authors:  Hou-Shi Ma; Elaine Lu Wang; Wen-Fei Xu; Shozo Yamada; Katsuhiko Yoshimoto; Zhi Rong Qian; Long Shi; Li-Li Liu; Xu-Hui Li
Journal:  Med Sci Monit       Date:  2018-07-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.